Quantitative Structure Activity Relationship Studies of Piperazinyl Phenylalanine Derivatives as VLA-4/VCAM-1 Inhibitors.

Dinesh Bhargava, C Karthikeyan, N S H N Moorthy, Piyush Trivedi

School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Airport Bypass Road, Gandhi Nagar, Bhopal-462036, Madhya Pradesh, India. .

Journal Article: Medicinal chemistry (Shāriqah (United Arab Emirates)) (impact factor: 1.64). 10/2009;

Abstract

QSAR study was carried out for a series of piperazinyl phenylalanine derivatives exhibiting VLA-4/VCAM-1 inhibitory activity to find out the structural features responsible for the biological activity. The QSAR study was carried out on V-life Molecular Design Suite software and the derived best QSAR model by partial least square (forward) regression method showed 85.67% variation in biological activity. The statistically significant model with high correlation coefficient (r2=0.85) was selected for further study and the resulted validation parameters of the model, crossed squared correlation coefficient (q2=0.76 and pred_r2=0.42) show the model has good predictive ability. The model showed that the parameters SaaNEindex, SsClcount slogP,and 4PathCount are highly correlated with VLA-4/VCAM-1 inhibitory activity of piperazinyl phenylalanine derivatives. The result of the study suggests that the chlorine atoms in the molecule and fourth order fragmentation patterns in the molecular skeleton favour VLA-4/VCAM inhibition shown by the title compounds whereas lipophilicity and nitrogen bonded to aromatic bond are not conducive for VLA-4/VCAM-1 inhibitory activity.

Source: PubMed

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

Science & Research Jobs

Keywords

biological activity
 
correlation coefficient
 
fourth order fragmentation patterns
 
molecular skeleton favour VLA-4/VCAM inhibition
 
nitrogen
 
parameters SaaNEindex
 
QSAR model
 
QSAR study
 
resulted validation parameters
 
squared correlation coefficient
 
statistically significant model
 
structural features responsible
 
title compounds
 
V-life Molecular Design Suite software
 
VLA-4/VCAM-1 inhibitory activity